Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disturbance; Vision, Loss”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Not applicableStudy completedNCT05456581
What this trial is testing

Scotoma Perimetry Oculomotor Training

Who this might be right for
Macular DegenerationCentral Visual Impairment
University of Alabama at Birmingham 21
Not applicableLooking for participantsNCT07134777
What this trial is testing

Mechanisms of Visual Restoration After Occipital Stroke

Who this might be right for
Cortical BlindnessStroke IschemicVision Loss Partial+4 more
University of Rochester 100
Not applicableStudy completedNCT01598818
What this trial is testing

First-Sight Refractive Error Correction in the Developing World

Who this might be right for
Vision Loss
University of Nebraska 150
Not applicableStudy completedNCT03626207
What this trial is testing

Development of Visual Function Evaluation Method (2)

Who this might be right for
Retinitis Pigmentosa
Astellas Pharma Inc 8
Early research (Phase 1)Study completedNCT04925687
What this trial is testing

Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
University of California, Davis 4
Not applicableEnded earlyNCT01415453
What this trial is testing

Evoked Retinal Response

Who this might be right for
Retinitis Pigmentosa
Columbia University 1
Not applicableActive Not RecruitingNCT05439759
What this trial is testing

Factors in Learning And Plasticity: Healthy Vision

Who this might be right for
Central Visual ImpairmentMacular Degeneration
University of Alabama at Birmingham 120
Not applicableStudy completedNCT05065788
What this trial is testing

Ophthalmological Emergencies and COVID-19 Pandemia

Who this might be right for
TraumaInfectionsVision; Loss, Both Eyes
Università degli Studi dell'Insubria 500
Not applicableStudy completedNCT05098236
What this trial is testing

Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage

Who this might be right for
Vision Loss PartialHemianopiaHemianopia Homonymous+2 more
University of Rochester 280
Testing effectiveness (Phase 2)Study completedNCT00958360
What this trial is testing

Low Vision Intervention Trial II (LOVIT II)

Who this might be right for
Central Vision Loss From Macular Diseases
VA Office of Research and Development 323
Large-scale testing (Phase 3)UnknownNCT00559715
What this trial is testing

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab

Who this might be right for
Age-Related Neovascular Macular Degeneration
Klinikum Bremen-Mitte, gGmbH 366
Not applicableStudy completedNCT01983488
What this trial is testing

Clinical Outcome in Uveitis

Who this might be right for
Uveitis
Moorfields Eye Hospital NHS Foundation Trust 231
Not applicableLooking for participantsNCT07085533
What this trial is testing

Natural History Study of Inherited Retinal Diseases

Who this might be right for
Retinal DystrophiesColor Vision DefectsVision Disorders+7 more
Zhongmou Therapeutics 200
Post-approval studies (Phase 4)Ended earlyNCT01214070
What this trial is testing

Functional Vision in TBI

Who this might be right for
Brain InjuriesVisually Impaired Persons
VA Office of Research and Development 110
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Not applicableEnrolling By InvitationNCT07246915
What this trial is testing

Long-term Safety & Performance of REVISYON SDS100 in Mild to Moderate Cataract: Extension Study (EB-CE-02)

Who this might be right for
Age-related CataractVision LossCataract+2 more
Edinburgh Biosciences Ltd 61
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Testing effectiveness (Phase 2)UnknownNCT01249937
What this trial is testing

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Who this might be right for
Wet Macular Degeneration
University Health Network, Toronto 30
Not applicableStudy completedNCT04043949
What this trial is testing

The Influences of Dry Eye Disease on Optical Quality

Who this might be right for
Dry EyeVision; Disturbance, Hysterical
Peking University Third Hospital 90
Load More Results